Cargando…
Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
BACKGROUND: The persistence and effectiveness of systemic therapies for moderate‐to‐severe psoriasis in current clinical practice are poorly characterized. OBJECTIVES: To systematically review observational studies investigating the persistence and effectiveness of acitretin, ciclosporin, fumaric ac...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766878/ https://www.ncbi.nlm.nih.gov/pubmed/30628069 http://dx.doi.org/10.1111/bjd.17625 |
_version_ | 1783454788804935680 |
---|---|
author | Mason, K.J. Williams, S. Yiu, Z.Z.N. McElhone, K. Ashcroft, D.M. Kleyn, C.E. Jabbar‐Lopez, Z.K. Owen, C.M. Reynolds, N.J. Smith, C.H. Wilson, N. Warren, R.B. Griffiths, C.E.M. |
author_facet | Mason, K.J. Williams, S. Yiu, Z.Z.N. McElhone, K. Ashcroft, D.M. Kleyn, C.E. Jabbar‐Lopez, Z.K. Owen, C.M. Reynolds, N.J. Smith, C.H. Wilson, N. Warren, R.B. Griffiths, C.E.M. |
author_sort | Mason, K.J. |
collection | PubMed |
description | BACKGROUND: The persistence and effectiveness of systemic therapies for moderate‐to‐severe psoriasis in current clinical practice are poorly characterized. OBJECTIVES: To systematically review observational studies investigating the persistence and effectiveness of acitretin, ciclosporin, fumaric acid esters (FAE) and methotrexate, involving at least 100 adult patients with moderate‐to‐severe psoriasis, exposed to therapy for ≥ 3 months. METHODS: MEDLINE, Embase, the Cochrane Library and PubMed were searched from 1 January 2007 to 1 November 2017 for observational studies reporting on persistence (therapy duration or the proportion of patients discontinuing therapy during follow‐up) or effectiveness [improvements in Psoriasis Area and Severity Index (PASI) or Physician's Global Assessment (PGA)]. This review was registered with PROSPERO, number CRD42018099771. RESULTS: Of 411 identified studies, eight involving 4624 patients with psoriasis were included. Variations in the definitions and analyses of persistence and effectiveness outcomes prevented a meta‐analysis from being conducted. One prospective multicentre study reported drug survival probabilities of 23% (ciclosporin), 42% (acitretin) and 50% (methotrexate) at 1 year. Effectiveness outcomes were not reported for either acitretin or ciclosporin. The persistence and effectiveness of FAE and methotrexate were better characterized, but mean discontinuation times ranged from 28 to 50 months for FAE and 7·7 to 22·3 months for methotrexate. At 12 months of follow‐up, three studies reported that 76% (FAE), 53% (methotrexate) and 59% (methotrexate) of patients achieved ≥ 75% reduction in PASI, and one reported that 76% of FAE‐exposed patients achieved a markedly improved or clear PGA. CONCLUSIONS: The comparative persistence and effectiveness of acitretin, ciclosporin, FAE and methotrexate in real‐world clinical practice in the past decade cannot be well described due to the inconsistency of the methods used. |
format | Online Article Text |
id | pubmed-6766878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67668782019-10-01 Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review Mason, K.J. Williams, S. Yiu, Z.Z.N. McElhone, K. Ashcroft, D.M. Kleyn, C.E. Jabbar‐Lopez, Z.K. Owen, C.M. Reynolds, N.J. Smith, C.H. Wilson, N. Warren, R.B. Griffiths, C.E.M. Br J Dermatol Evidence‐Based Dermatology BACKGROUND: The persistence and effectiveness of systemic therapies for moderate‐to‐severe psoriasis in current clinical practice are poorly characterized. OBJECTIVES: To systematically review observational studies investigating the persistence and effectiveness of acitretin, ciclosporin, fumaric acid esters (FAE) and methotrexate, involving at least 100 adult patients with moderate‐to‐severe psoriasis, exposed to therapy for ≥ 3 months. METHODS: MEDLINE, Embase, the Cochrane Library and PubMed were searched from 1 January 2007 to 1 November 2017 for observational studies reporting on persistence (therapy duration or the proportion of patients discontinuing therapy during follow‐up) or effectiveness [improvements in Psoriasis Area and Severity Index (PASI) or Physician's Global Assessment (PGA)]. This review was registered with PROSPERO, number CRD42018099771. RESULTS: Of 411 identified studies, eight involving 4624 patients with psoriasis were included. Variations in the definitions and analyses of persistence and effectiveness outcomes prevented a meta‐analysis from being conducted. One prospective multicentre study reported drug survival probabilities of 23% (ciclosporin), 42% (acitretin) and 50% (methotrexate) at 1 year. Effectiveness outcomes were not reported for either acitretin or ciclosporin. The persistence and effectiveness of FAE and methotrexate were better characterized, but mean discontinuation times ranged from 28 to 50 months for FAE and 7·7 to 22·3 months for methotrexate. At 12 months of follow‐up, three studies reported that 76% (FAE), 53% (methotrexate) and 59% (methotrexate) of patients achieved ≥ 75% reduction in PASI, and one reported that 76% of FAE‐exposed patients achieved a markedly improved or clear PGA. CONCLUSIONS: The comparative persistence and effectiveness of acitretin, ciclosporin, FAE and methotrexate in real‐world clinical practice in the past decade cannot be well described due to the inconsistency of the methods used. John Wiley and Sons Inc. 2019-03-27 2019-08 /pmc/articles/PMC6766878/ /pubmed/30628069 http://dx.doi.org/10.1111/bjd.17625 Text en © 2019 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Evidence‐Based Dermatology Mason, K.J. Williams, S. Yiu, Z.Z.N. McElhone, K. Ashcroft, D.M. Kleyn, C.E. Jabbar‐Lopez, Z.K. Owen, C.M. Reynolds, N.J. Smith, C.H. Wilson, N. Warren, R.B. Griffiths, C.E.M. Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review |
title | Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
|
title_full | Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
|
title_fullStr | Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
|
title_full_unstemmed | Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
|
title_short | Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
|
title_sort | persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review |
topic | Evidence‐Based Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766878/ https://www.ncbi.nlm.nih.gov/pubmed/30628069 http://dx.doi.org/10.1111/bjd.17625 |
work_keys_str_mv | AT masonkj persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT williamss persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT yiuzzn persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT mcelhonek persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT ashcroftdm persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT kleynce persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT jabbarlopezzk persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT owencm persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT reynoldsnj persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT smithch persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT wilsonn persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT warrenrb persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview AT griffithscem persistenceandeffectivenessofnonbiologicsystemictherapiesformoderatetoseverepsoriasisinadultsasystematicreview |